España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Alzamend Neuro
ALZN
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.11
-0.14
-11.20%
At close: -
$1.12
0.01
0.90%
After Hours: Dec 20, 6:49 PM EDT
Get Report
Comment
Alzamend Neuro (ALZN) Forecast
News
Earnings
Alzamend Neuro (ALZN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Alzamend Neuro (NASDAQ:ALZN) Stock
Alzamend Neuro Stock (NASDAQ: ALZN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, December 18, 2024
Alzamend Neuro To Present Non-Clinical Data U...
Benzinga Newsdesk
Monday, December 16, 2024
Ascendiant Capital Maintains Buy on Alzamend ...
Benzinga Newsdesk
Thursday, December 12, 2024
Alzamend Neuro Q2 EPS $(0.40) Beats $(0.77) E...
Benzinga Newsdesk
Tuesday, November 19, 2024
EXCLUSIVE: Alzamend Neuro Reveals Full Data From Nonclinical Study Of Its Lead Alzheimer's Drug Potential
Vandana Singh
EXCLSUIVE: Alzamend Neuro Tells Benzinga 'Dat...
Benzinga Newsdesk
EXCLSUIVE: Alzamend Neuro Tells Benzinga Co. ...
Benzinga Newsdesk
Monday, November 11, 2024
Ascendiant Capital Maintains Buy on Alzamend ...
Benzinga Newsdesk
Wednesday, October 16, 2024
EXCLUSIVE: Alzamend Neuro Reveals Full Data Set From Multiple Ascending Dose Trial For Lead Candidate For Dementia Related to Alzheimer's
Vandana Singh
EXCLUSIVE: Alzamend Neuro Tells Benzinga 'Ide...
Benzinga Newsdesk
EXCLUSIVE: Alzamend Neuro Tells Benzinga 'Dat...
Benzinga Newsdesk
EXCLUSIVE: Alzamend Neuro Tells Benzinga Anno...
Benzinga Newsdesk
Tuesday, October 15, 2024
Alzamend Neuro Regains Compliance With Nasdaq...
Benzinga Newsdesk
Tuesday, August 20, 2024
Why Bit Digital Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Nvidia, AMD, Alzamend Neuro, Palo Alto Networks, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Benzinga Neuro
Monday, August 19, 2024
Nasdaq Surges 150 Points; Sonder Holdings Shares Surge
Avi Kapoor
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Crude Oil Down 2%; Alzamend Neuro Shares Spike Higher
Avi Kapoor
Alzamend Neuro Shares Resumed Trade
Benzinga Newsdesk
Dow Jumps Over 100 Points; Estee Lauder Shares Edge Lower After Q4 Results
Avi Kapoor
Alzamend Neuro Shares halted On Circuit Break...
Benzinga Newsdesk
Alzamend Neuro Shares Resume Trade
Benzinga Newsdesk
Alzamend Neuro Shares halted On Circuit Break...
Benzinga Newsdesk
Alzamend Neuro Stock Jumps After Post Traumatic Stress Disorder Study Pact: Details
Vandana Singh
Market-Moving News for August 19th
Benzinga Newsdesk
Alzamend Neuro shares are trading higher afte...
Benzinga Newsdesk
Alzamend Neuro Partners With Massachusetts Ge...
Benzinga Newsdesk
Monday, August 12, 2024
Alzamend Neuro Partners With Massachusetts Ge...
Benzinga Newsdesk
Monday, August 05, 2024
Alzamend Neuro shares are trading higher afte...
Benzinga Newsdesk
EXCLUSIVE: Alzamend Neuro Tells Benzinga 'the...
Benzinga Newsdesk
EXCLUSIVE: Alzamend Neuro To Assess AL001 Alzheimer's Candidate Against Commonly Marketed Lithium Salt In Phase 2 Head-To-Head Study
Vandana Singh
EXCLUSIVE: Alzamend Neuro Tells Benzinga 'Hea...
Benzinga Newsdesk
EXCLUSIVE: Alzamend Neuro Tells Benzinga Co. ...
Benzinga Newsdesk
Wednesday, July 31, 2024
Alzamend Neuro Regains Compliance With Nasdaq...
Benzinga Newsdesk
Tuesday, July 16, 2024
Trading Halt: Halt status updated at 8:55:00 ...
Benzinga Newsdesk
Monday, July 15, 2024
Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk
Friday, July 12, 2024
Alzamend Neuro Announces 1-For-10 Reverse Sto...
Benzinga Newsdesk
Thursday, June 20, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Friday, June 14, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, June 13, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Wednesday, May 22, 2024
Nasdaq Hearings Panel Granted Alzamend's Requ...
Benzinga Newsdesk
Friday, May 10, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, May 09, 2024
Alzamend Neuro shares are trading higher afte...
Benzinga Newsdesk
EXCLUSIVE: Alzamend Neuro To Raise Up To $25M Via Private Placement Of Preferred Shares
Vandana Singh
EXCLUSIVE: Alzamend Neuro Tells Benzinga Co. ...
Benzinga Newsdesk
Wednesday, May 08, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Tuesday, May 07, 2024
Alzamend Neuro Halts Equity Offering Program,...
Benzinga Newsdesk
Alzamend Neuro shares are trading lower after...
Benzinga Newsdesk
Alzamend Neuro Announces Termination Of At-Th...
Benzinga Newsdesk
Friday, May 03, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Wednesday, April 24, 2024
Alzamend Neuro And 2 Other Stocks Under $5 Insiders Are Buying
Avi Kapoor
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch